In a new job - November 30, 2021
Lundbeck announces executive management changes
Lundbeck has announced that Jacob Tolstrup, Executive Vice President for Commercial Operations, is promoted to Chief Commercial Officer, effective 1 January 2022. Jacob will be responsible for sales and marketing across all Lundbeck affiliates worldwide. Also, Peter Anastasiou, Executive Vice President for North America, has decided to leave Lundbeck at the end of the year […]
In a new job - November 22, 2021
XNK Therapeutics adds three scientific advisors
XNK Therapeutics has announced the strengthening of the company’s expertise by the appointment of Ola Landgren, Fredrik Schjesvold and Johan Lund. These scientific advisors are key to the company’s plan to further expand the scope of its proprietary technology platform of natural killer (NK) cell therapies within plasma cell disorders and hematological malignancies, the company […]
In a new job - November 20, 2021
BICO appoints new member of the board
BICO has added Susan Tousi to its Board of Directors. Tousi has spent nearly a decade at Illumina, where she currently leads the global commercial organization. Tousi was approved unanimously during an Extraordinary General Meeting (EGM) of the Board of Directors. As the leader of Illumina’s commercial organization, Tousi will bring invaluable strategic insights and […]
In a new job - November 15, 2021
He is the new CEO of Oncopeptides
The Board of Directors has appointed Jakob Lindberg as Chief Executive Officer, CEO of Oncopeptides. Jakob Lindberg replaces Marty J Duvall, who has been the CEO since July 1, 2020. These changes are effective immediately. Returns to being a Sweden based R&D company The leadership changes follows the withdrawal of Pepaxto (INN melphalan flufenamide) from […]
In a new job - November 12, 2021
Coripharma makes two key appointments
Coripharma has announced that Stefan Karlsson is joining the company as Senior Sourcing Manager and Fjalar Jóhannsson has been appointed as Portfolio Manager. “We are delighted to welcome Stefan to Coripharma and Fjalar to his new role of as Portfolio Manager,” says Jonina Gudmundsdottir, CEO, Coripharma. “Their deep industry expertise, extensive experience within R&D, Stefan‘s […]
In a new job - November 9, 2021
Oncopeptides appoints new interim CFO
Oncopeptides has appointed Annika Muskantor as interim Chief Financial Officer, CFO. Muskantor has an extensive experience as interim CFO from a broad range of industries including the life science industry, and she assumed her position on November 8. The appointment follows the previously announced resignation by CFO Anders Martin-Löf. Photo: iStock
